NCT04893720

Brief Summary

The aim of the present study is to find out whether fusion of multilevel SPECT/CT positive lumbar degeneration leads to a significant improvement of pain and disability.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
1mo left

Started Jun 2021

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Jun 2021Jun 2026

First Submitted

Initial submission to the registry

May 15, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 19, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

4 years

First QC Date

May 15, 2021

Last Update Submit

March 11, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Oswestry Disability Index (ODI)

    The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire. The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. he scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.

    2 years

  • Change in Pain Visual Analogue Scale (VAS)

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between VAS 0 (no pain) and VAS 10 (worst pain).

    2 years

Interventions

Lumbar fusionPROCEDURE

Transforaminal Lumbar Interbody Fusion of the SPECT/CT positive lumbar degeneration

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

An open prospective cohort study will be performed. Inclusion criteria will be: subjects between 18 and 75 years of age; both genders; with CBP and diagnosis of DDD or facet arthropathy on MRI and increased metabolic activity on bone SPECT/CT imaging in the same levels who are undergoing open lumbar interbody fusion. New MRI of the lumbar spine and SPECT/CT will be performed 2 years after the surgical procedure. The patients will complete ODI and VAS questionnaires before surgery and at 6- and 24-months follow-up visits. All patients will sign an informed consent form.

You may qualify if:

  • Lower back pain (in extension +/- pain in buttocks, groin, thigh) without radicular pain
  • Symptoms \> 6 months after the failure of conservative management in the primary care setting
  • MRI signs of degenerative disc disease or facet arthropathy
  • Two- or more levels of positivity on lumbar SPECT/CT

You may not qualify if:

  • Other spinal pathology (tumors, congenital defects, spondylolysis, or spondylolisthesis)
  • Intolerance of SPECT examination
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Military University Hospital Prague

Prague, 16902, Czechia

RECRUITING

University Hospital, Motol

Prague, Czechia

RECRUITING

MeSH Terms

Conditions

Intervertebral Disc Degeneration

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Jaroslav Plas

    jaroslav.plas@uvn.cz

    STUDY CHAIR

Central Study Contacts

Jaroslav Plas

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 15, 2021

First Posted

May 19, 2021

Study Start

June 1, 2021

Primary Completion

June 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

March 13, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations